XML 33 R76.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Statements of Cash flows (Detail) (USD $)
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Cash flows from operating activities:        
Net income attributable to Noah shareholders $ 22,826,454 $ 23,969,950 $ 11,530,369  
Adjustment to reconcile net income to net cash provided by operating activities:        
Share-based compensation 3,998,548 2,156,710 2,220,167  
Gain on change in fair value of derivative liabilities     (354,000) 796,500
Changes in operating assets and liabilities:        
Amount due from related party (2,740,357) (667,489) (1,017,434)  
Other current assets (1,090,320) 42,358 (1,692,942)  
Deferred tax assets (476,354) (1,657,344) (1,486,148)  
Uncertain tax position liabilities (156,289) 168,926 98,577  
Other current liabilities 7,045,670 652,625 2,689,400  
Other non-current liabilities 227,196 896,987 957,775  
Net cash provided by (used in) operating activities 29,953,666 21,286,623 21,431,109  
Cash flows from investing activities:        
Investment in subsidiaries and VIE (2,978,360) (1,554,229) (885,119)  
Net cash used in investing activities (34,565,150) (20,818,246) (6,149,500)  
Cash flows from financing activities:        
Gross proceeds from issuance of ordinary shares in the initial public offering (Issuance costs of) refunds from the     115,920,000  
initial public offering   31,022 (10,777,495)  
Proceeds from issuance of ordinary shares upon exercise of stock options 407,569 649,672    
Share repurchase (8,520,763)      
Net cash provided by (used in) financing activities (13,791,999) 680,694 105,142,505  
Net increase (decrease) in cash and cash equivalents (17,298,184) 3,589,642 121,153,923  
Cash and cash equivalents- beginning of year 136,859,336 133,269,694 12,115,771  
Cash and cash equivalents- end of year 119,561,152 136,859,336 133,269,694 12,115,771
Parent Company
        
Cash flows from operating activities:        
Net income attributable to Noah shareholders 22,826,454 23,969,950 11,530,369  
Adjustment to reconcile net income to net cash provided by operating activities:        
Share-based compensation 487,435 2,156,710 2,220,167  
Gain on change in fair value of derivative liabilities     (354,000)  
Gain from equity in subsidiaries and VIE (23,539,869) (22,373,127) (13,594,538)  
Changes in operating assets and liabilities:        
Amount due from related party 405,905 (18,788) 229,641  
Other current assets (223,065) 1,039,117 (1,236,480)  
Deferred tax assets 52,879 (467,096)    
Uncertain tax position liabilities 169,389 168,926 98,579  
Other current liabilities (419,372) (144,901) 903,575  
Other non-current liabilities (173,576) 401,905 957,775  
Net cash provided by (used in) operating activities (413,820) 4,732,696 755,088  
Cash flows from investing activities:        
Increase in amount due from subsidiaries and VIEs (17,000,000) (23,000,000)    
Investment in subsidiaries and VIE   (3,855,366)    
Net cash used in investing activities (17,000,000) (26,855,366)    
Cash flows from financing activities:        
Gross proceeds from issuance of ordinary shares in the initial public offering (Issuance costs of) refunds from the     115,920,000  
initial public offering   31,022 (10,777,494)  
Dividends paid (7,856,908)   (108,348)  
Proceeds from issuance of ordinary shares upon exercise of stock options 407,569 649,673    
Share repurchase (8,520,763)      
Net cash provided by (used in) financing activities (15,970,102) 680,695 105,034,158  
Net increase (decrease) in cash and cash equivalents (33,383,922) (21,441,975) 105,789,246  
Cash and cash equivalents- beginning of year 84,371,832 105,813,807 24,561  
Cash and cash equivalents- end of year $ 50,987,910 $ 84,371,832 $ 105,813,807